Maravai Lifesciences Holdings, Inc. financial data

Symbol
MRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10770 Wateridge Circle Suite 200, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 924 % +33.4%
Quick Ratio 66 % +38.7%
Debt-to-equity 220 % -20.3%
Return On Equity -15.6 % -187%
Return On Assets -7.02 % -203%
Operating Margin -19.4 % -134%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 1.37B USD -56.1%
Weighted Average Number of Shares Outstanding, Basic 132M shares +0.45%
Weighted Average Number of Shares Outstanding, Diluted 132M shares +0.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 274M USD -61.8%
Cost of Revenue 153M USD -5.66%
Research and Development Expense 18.2M USD -3.47%
Costs and Expenses 327M USD +6.09%
Operating Income (Loss) -53M USD -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 600M USD +57.8%
Income Tax Expense (Benefit) 760M USD +1917%
Net Income (Loss) Attributable to Parent -131M USD -185%
Earnings Per Share, Basic -0.99 USD/shares -185%
Earnings Per Share, Diluted -0.99 USD/shares -185%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 562M USD
Accounts Receivable, after Allowance for Credit Loss, Current 36.7M USD -34.8%
Inventory, Net 49.8M USD -9.07%
Assets, Current 668M USD -12.8%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 163M USD +209%
Operating Lease, Right-of-Use Asset 59.7M USD -6.5%
Intangible Assets, Net (Excluding Goodwill) 214M USD -11.4%
Goodwill 326M USD -0.17%
Other Assets, Noncurrent 75M USD -41%
Assets 1.44B USD -37.6%
Accounts Payable, Current 4.78M USD -53.9%
Employee-related Liabilities, Current 9.86M USD -52.8%
Accrued Liabilities, Current 35.4M USD -49.5%
Contract with Customer, Liability, Current 2.21M USD +7.65%
Liabilities, Current 59M USD -52.7%
Deferred Income Tax Liabilities, Net 6.69M USD
Operating Lease, Liability, Noncurrent 47.5M USD -7.85%
Other Liabilities, Noncurrent 58.6M USD -11.2%
Liabilities 667M USD -52.8%
Retained Earnings (Accumulated Deficit) 274M USD -32.4%
Stockholders' Equity Attributable to Parent 411M USD -21.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 777M USD -13.7%
Liabilities and Equity 1.44B USD -37.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.47M USD -110%
Net Cash Provided by (Used in) Financing Activities -560K USD +97.1%
Net Cash Provided by (Used in) Investing Activities -4.24M USD +93.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.3M USD -243%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 562M USD -10.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1M USD +26.6%
Deferred Tax Assets, Valuation Allowance 642M USD +2601%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 642M USD -18.7%
Operating Lease, Liability 54.3M USD -6.11%
Depreciation 15.6M USD +100%
Payments to Acquire Property, Plant, and Equipment 5.67M USD -28%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -131M USD -185%
Lessee, Operating Lease, Liability, to be Paid 73.3M USD -7.39%
Operating Lease, Liability, Current 6.97M USD +3.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.4M USD +0.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.2M USD +3.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19M USD -10.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10M USD -3.34%
Deferred Tax Assets, Operating Loss Carryforwards 41M USD
Deferred Federal Income Tax Expense (Benefit) 664M USD +1563%
Current Income Tax Expense (Benefit) 1.17M USD -93.7%
Unrecognized Tax Benefits 5.2M USD -16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.56M USD -9.46%
Operating Lease, Payments 10.3M USD +46.2%
Additional Paid in Capital 134M USD +17.6%
Current State and Local Tax Expense (Benefit) 756K USD -65.2%
Current Federal Tax Expense (Benefit) 405K USD -97.5%
Amortization of Intangible Assets 6.87M USD +1.54%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 40.7M USD +93.3%
Deferred State and Local Income Tax Expense (Benefit) 91M USD +3700%
Interest Expense 44.9M USD +51.9%